SR 124 (BR 1819) - J. Denton
Urge Congress to pass legislation to bring biosimilar drugs to American patients, preserve incentives for continued pharmaceutical innovation, and protect public health.
Mar 4-introduced in Senate
Mar 6-to Health & Welfare (S)
Mar 11-reported favorably, 1st reading, to Consent Calendar
Mar 12-2nd reading, to Rules